BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+96.8%
5Y CAGR+51.2%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+96.8%/yr
vs +3.6%/yr prior
5Y CAGR
+51.2%/yr
Recent acceleration
Acceleration
+93.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
7.9x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $147893.00 | +29.0% |
| 2024 | $114643.00 | +459.0% |
| 2023 | $20508.00 | +5.6% |
| 2022 | $19417.00 | -0.2% |
| 2021 | $19462.00 | +3.9% |
| 2020 | $18735.00 | -0.5% |
| 2019 | $18833.00 | +11.6% |
| 2018 | $16877.00 | +5725.5% |
| 2017 | $289.71 | -83.9% |
| 2016 | $1803.00 | - |